Cases 1 - 5 of 5
Barnes v. Bristol-Myers Squibb Company et al
as 5:2018cv00054
Plaintiff:
Kathy Barnes
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
In re: Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Products Liability Litigation MDL 2809
as 5:2018md02809
Defendant:
Onglyza (Saxagliptin) and Kombiglyze (Saxagliton and Metformin) Products Liability Litigation MDL 2809, McKesson Corporation, Bristol-Myers Squibb Company, Inc. and others
Plaintiff:
Susan Settle, Charles David Ware, William Dinger Sr. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Barnes v. Bristol-Myers Squibb Company et al
as 2:2017cv00124
Plaintiff:
Kathy Barnes
Defendant:
Bristol-Myers Squibb Company , AstraZeneca Pharmaceuticals LP and McKesson Corporation
Cause Of Action: 28 U.S.C. § 1332
Jasmin et al v. McKesson Corporation et al
as 2:2016cv00123
Plaintiff:
Juana Jasmin , Steven Jordan , Peter Ligotti and others
Defendant:
Eli Lilly and Company , aaiPharma Inc, aaiPharma LLC and others
Cause Of Action: 28 U.S.C. § 1332
Jasmin et al v. McKesson Corporation et al
as 2:2013cv00076
Plaintiff:
Juana Jasmin , Steven Jordan , Peter Ligotti and others
Defendant:
McKesson Corporation , Eli Lilly and Company, aaiPharma Inc and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Account Receivable
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
